Patients should receive training on the proper use of the delivery device prior to starting treatment. The Food and Drug Administration (FDA) has approved Onapgo™ (apomorphine hydrochloride [HCl]) for ...

Vyalev combines foscarbidopa, a prodrug of carbidopa, and foslevodopa, a prodrug of levodopa, into a solution for continuous subcutaneous 24-hour infusion. The Food and Drug Administration (FDA) has ...

AstraZeneca (AZN) said that Saphnelo has been recommended for approval in the European Union as a self-administered once-weekly pre-filled pen for ...

Hickory, N.C.-based Gastroenterology Associates added an infusion center to provide long-term infusion services to its clients with gastrointestinal diseases, the Hickory Daily Record reports. The ...

Leqembi Iqlik, a subcutaneous formation of lecanemab, is now available as a maintenance dosing regimen for the treatment of early Alzheimer disease.

Researchers sought to determine whether subcutaneous isatuximab would be an effective treatment for patients with RRMM.